Application
Fig1: Western blot analysis of SALL4 on human SALL4 recombinant protein using anti-SALL4 antibody at 1/1,000 dilution.Application
Fig2: Western blot analysis of SALL4 on HEK293 (1) and SALL4-hIgGFc transfected HEK293 (2) cell lysate using anti-SALL4 antibody at 1/1,000 dilution.Application
Fig3: Flow cytometric analysis of Hela cells with SALL4 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).| Product Name | SALL4 [A4-E11] |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | AA407717 antibody AL022809 antibody AW536104 antibody C330011P20Rik antibody C78083 antibody C78563 antibody dJ1112F19.1 antibody DRRS antibody HSAL4 antibody Sal like 4 (Drosophila) antibody Sal like 4 antibody Sal like Protein 4 antibody Sal-like protein 4 antibody Sall4 antibody SALL4_HUMAN antibody Spalt like transcription factor 4 antibody Tex20 antibody Zinc finger protein 797 antibody Zinc finger protein SALL4 antibody ZNF797 antibody |
| Product description | Sall3 (SALL3, sal-like 3) and Sall4 (SALL4, sal-like 4) are mammalian homologs of the Drosophila region-specific homeotic gene spalt, which encodes a zinc finger-containing transcription regulator. Drosophila spalt is an essential genetic component required for the specification of posterior head and anterior tail as opposed to trunk. Sall3 is expressed at 24 weeks of gestation in several regions of the human fetal brain including neurons of the hippocampus formation and of mediodorsal and ventrolateral thalamic nuclei, Purkinje cells of the cerebellum, and a subset of neurons in the brainstem. Sall4 expression in early mouse embryos is gradually confined to the head region and the primitive streak, followed by prominent expression in the developing midbrain, branchial arches, limbs and genital papilla. |
| Immunogen | Recombinant protein |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG2a |
| Host Species | Mouse |
| Tested Applications | WBFC |
| WB:1:500-1:2,000 FC:1:100-1:200 |
|
| Species Reactivity | Human |
| Concentration | 2mg/ml |
| Alternative Names | AA407717 antibody AL022809 antibody AW536104 antibody C330011P20Rik antibody C78083 antibody C78563 antibody dJ1112F19.1 antibody DRRS antibody HSAL4 antibody Sal like 4 (Drosophila) antibody Sal like 4 antibody Sal like Protein 4 antibody Sal-like protein 4 antibody Sall4 antibody SALL4_HUMAN antibody Spalt like transcription factor 4 antibody Tex20 antibody Zinc finger protein 797 antibody Zinc finger protein SALL4 antibody ZNF797 antibody |
|---|---|
| Molecular Weight(MW) | 112 kDa |
| Cellular Localization | Nucleus. |
| SwissProt ID | Q9UJQ4 |
|---|
Application
Fig1: Western blot analysis of SALL4 on human SALL4 recombinant protein using anti-SALL4 antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of SALL4 on HEK293 (1) and SALL4-hIgGFc transfected HEK293 (2) cell lysate using anti-SALL4 antibody at 1/1,000 dilution.
Application
Fig3: Flow cytometric analysis of Hela cells with SALL4 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).| Positive Control | Human SALL4 recombinant protein, SALL4-hIgGFc transfected HEK293 cell lysate, Hela. |
|---|---|
| Application Notes | WB:1:500-1:2,000 FC:1:100-1:200 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
